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Introduction {#sec001}
============

Continuous or dynamic cardiac function monitoring plays a crucial role in the diagnosis, assessment, treatment, and prognosis of critically ill patients. Cardiac output (CO) measurement is one of the most important parameters in cardiac function monitoring. The commonly used CO measurement methods include indirect Fick methods, thermodilution (TD), Doppler ultrasound (US) or echocardiography, partial carbon dioxide (CO~2~) rebreathing, thoracic electrical bioimpedance, and magnetic resonance imaging \[[@pone.0222105.ref001], [@pone.0222105.ref002]\]. TD via the pulmonary artery (PA) catheter is still considered to be the gold standard method in the clinical setting. However, this method has disadvantages because it is invasive and can lead to severe complications \[[@pone.0222105.ref003]\]. Echocardiography, as a noninvasive or semi-invasive method for the assessment of cardiac anatomy and function, is favored in clinical practice. The methods commonly used for echocardiography include transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), ultrasonic CO monitor (USCOM), noninvasive continuous CO system (NICO), and ultrasound dilution (UD). Several sites can be used for CO measuring. The velocity time integral (VTI) and cross-sectional area (CSA) of the ascending aorta (AA) \[[@pone.0222105.ref004]\], PA \[[@pone.0222105.ref005]\], aortic valve (AOV) \[[@pone.0222105.ref006]\], mitral valve \[[@pone.0222105.ref007]\], or left ventricular outflow tract (LVOT) \[[@pone.0222105.ref008]\]can be used to calculate the stroke volume (SV) using CSA×VTI and the CO = SV×heart rate. Simpson's rule \[[@pone.0222105.ref009]\] was the first method to delineate the innermost endocardial border of the left ventricle using the trackball at end systolic and end diastolic and then to calculate the left ventricular end-diastolic volumes (LVEDV) and left ventricular end-systolic volumes (LVESV): CO = (LVEDV-LVESV)×heart rate. Some studies used the common carotid artery in point-of-care US to estimate the CO \[[@pone.0222105.ref010]\]. UD \[[@pone.0222105.ref011]\] technology is also used to measure hemodynamic variables based on the Stewart-Hamilton principle. This method utilizes an extracorporeal arteriovenous tubing loop (AV loop) inserted between existing arterial and venous catheters and isotonic saline as an indicator \[[@pone.0222105.ref012]\].

Whether echocardiography can replace TD method in CO measurement remains controversial. Some studies \[[@pone.0222105.ref013]--[@pone.0222105.ref015]\] have revealed that echocardiography is a rapid, accurate, and noninvasive monitoring technology suitable for patients in ICU. Although differences were observed, some studies \[[@pone.0222105.ref010], [@pone.0222105.ref016]\] showed the correlation was good. However, some studies \[[@pone.0222105.ref017], [@pone.0222105.ref018]\] suggested that echocardiography is not interchangeable with TD for measuring CO. Therefore, this study aimed to evaluate the consistency and interchangeability of cardiac output measurements in US and TD and to find the most optimal types or sites used of echocardiography for CO measuring if possible.

Materials and methods {#sec002}
=====================

This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis of diagnostic test accuracy (PRISMA-DTA) statement. Ethics committee approval was not required, as it was a review of published data.

Search strategy {#sec003}
---------------

An electronic literature search was performed in PubMed, EMBASE (using OVID), Cochrane Controlled Trials Registry, China National Knowledge infrastructure, and Wanfang Data from their inception up to June 2019. The EndNote X6 software (Thomson Reuters Corporation, New York, NY, USA) was used to eliminate duplicates and manage these citations. The following search strategy was used to identify studies:

1.  transtho\*\[Title/Abstract\] OR transeso\*\[Title/Abstract\] OR echocard\*\[Title/Abstract\] OR cardiac ultrasound \[Title/Abstract\] OR Doppler \[Title/Abstract\] OR USCOM \[Title/Abstract\]

2.  cardiac output \[Title/Abstract\]) AND thermodilution \[Title/Abstract\]

3.  \#1 AND \#2

Study selection {#sec004}
---------------

The inclusion criteria were (1) critically ill patients, (2) clinical trials, (3) studies that used echocardiography to measure the CO, (4) studies that used TD technique as the reference technique, and (5) studies in which outcomes of interest included the data of CO or all the differences between the techniques (bias) and standard deviations (SDs) or bias and limits of agreement (LOA).

The exclusion criteria were (1) reviews or case reports, (2) animal studies, (3) studies published in languages other than English, (4) studies only published as an abstract, and (5) studies with no mean and SD of CO and without bias and LOA/SD between two techniques.

Study selection and data extraction were performed by two independent reviewers (YZ and JS). Disagreements were resolved through consensus.

Data extraction {#sec005}
---------------

A data collection form was developed prior to data extraction. Two authors (YZ and YW) extracted relevant data from included articles. The extracted data included (1) first author and year of publication; (2) number of patients, sex, and age; (3) the data of CO in both groups; (4) the type of ultrasound and sites; (5) the bias, SD, LOA, and percentage error (PE); (6) the Pearson R coefficient and linear equations; and (7) patient population.

When the results of the trial were reported as median and quartile, the Stela Pudar-Hozo method was used to estimate the mean and standard deviation. Bias was defined as the mean of the two measurement differences, and LOA was defined as bias±1.96SD (some studies defined LOA as bias±2SD). The PE was defined as 1.96SD divided by the mean CO of the two methods. Posteriori probability was also calculated.

Ethics approval was waived for this study as patient consent was obtained within the individual trials and all data were anonymized.

Quality assessment {#sec006}
------------------

Studies with critically ill patients who needed CO monitoring were included. The CO measured by thermodilution was the reference standard, regardless of other modes of CO monitoring. Study quality was assessed using QUADAS-2, which was tailored for our systematic review ([S1 Table](#pone.0222105.s001){ref-type="supplementary-material"}). The quality of each paper was evaluated by two authors (YW and JS) independently, and any disagreements were resolved by consensus.

Statistical methods {#sec007}
-------------------

The systematic reviews were conducted in compliance with the PRISMA guidelines. The Review Manager Software version 5.3 for Windows (The Cochrane Collaboration, 2014) was used to perform the meta-analysis. The STATA version 12.0 (StataCorp, College Station, TX, USA) was used to analyze the publication bias (Egger's test). The Cochrane Q-test was used for heterogeneity analysis. A fixed-effect model was used when *P*\>0.1 and I^2^\<50%; otherwise, a random effects model was adopted. If necessary, a sensitivity analysis was performed to reduce the heterogeneity to *P*\>0.1 and I^2^\<25% by omission of some studies as few as possible. All P-values were two-sided, and P\<0.05 was considered significant.

Results {#sec008}
=======

Search results {#sec009}
--------------

Of the initial 808 records identified, 676 remained after duplicates were removed. Then, 477 records were excluded based on the title, and 83 records excluded based on the abstract; 116 articles were evaluated in full text. Forty-eight full-length articles were excluded, including 33 articles with missing data and 15 articles that used TD and US techniques, but not CO measurement, in the optimization of cardiac preload. Finally, 68 and 43 studies were included in qualitative synthesis and quantitative synthesis, respectively (meta-analysis) ([Fig 1](#pone.0222105.g001){ref-type="fig"}). All studies were published between 1971 and 2018 ([Table 1](#pone.0222105.t001){ref-type="table"}).

![Flowchart of identification of eligible studies.](pone.0222105.g001){#pone.0222105.g001}
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###### Main characteristics of the included studies.

![](pone.0222105.t001){#pone.0222105.t001g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Studies                                           N    Types of US   Sites     LOA     Bias    PE(%)   R      Linear equation or Notes   Population                                                    
  ------------------------------------------------- ---- ------------- --------- ------- ------- ------- ------ -------------------------- ------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------
  Arora 2007\[[@pone.0222105.ref019]\]              30   USCOM         AA        -0.86   0.59    0.13                                                                                                    OPCAB

  Axler 1996\[[@pone.0222105.ref020]\]              13   TEE           Simpson   -4.00   4.60    -0.30   26.0   0.680                                                                                    Mechanically ventilated critically ill patients

  Basdogan 2000\[[@pone.0222105.ref021]\]           33   ACM           LVOT      -2.35   2.52    -2.35          0.570                      COUS = 0.35COTD+3.55                                          Intensive care patients

  Beltramo 2016\[[@pone.0222105.ref022]\]           31   USCOM         AoV       -1.20   1.60    0.20    11.0   0.870                                                                                    Pediatric patients for heart transplantation, dilated/ hypertrophic / restrictive cardiomyopathy

  Bojanowski 1987\[[@pone.0222105.ref023]\]         12   TTE           AoV       0.10    1.20    0.60           0.880                      COUS = 1.26+0.87COTD                                          CHF, PH, MVD

  Botero 2004\[[@pone.0222105.ref024]\]             68   NICO          AA        -2.10   2.20    0.04    44.8                                                                                            CABG

  Cariou 1998\[[@pone.0222105.ref025]\]             20   USCOM         DA                        -2.31          0.800                                                                                    Critically ill patients with mechanical ventilation

  Castor 1994\[[@pone.0222105.ref002]\]             10   TTE           AA                        -0.70   16.0                              IPPV                                                          ASA-PS Ⅲ-Ⅳ

  Castor(1) 1994\[[@pone.0222105.ref002]\]          10   TTE           AA                        -0.70   18.7                              Apnoea                                                        ASA-PS Ⅲ-Ⅳ

  Castor(2) 1994\[[@pone.0222105.ref002]\]          10   TTE           AA                        -2.50   32.4                              Spontaneous ventilation                                       ASA-PS Ⅲ-Ⅳ

  Chand 2006\[[@pone.0222105.ref004]\]              50   USCOM         AA        -1.69   1.41    -0.14                                                                                                   OPCAB

  Chandraratna 2002\[[@pone.0222105.ref026]\]       50   TTE           PA        -0.48   0.96    0.24           0.920                      COUS = 0.93COTD+0.60                                          Patients in the coronary care department for treatment of CHF or hemodynamic instability

  Chew 2009\[[@pone.0222105.ref006]\]               12   TEE           AoV                       0.06                                                                                                    Severe sepsis and septic shock in the medical ICU

  Coats 1992\[[@pone.0222105.ref027]\]              6    TTE           AA        -1.71           -0.40                                     TD\>DU                                                        Ischemic heart disease, CHF or PH

  Corley 2009\[[@pone.0222105.ref028]\]             30   USCOM         AA        -1.40   0.70    0.34           0.848                                                                                    Evaluation for CHF and/or PH

  Crittendon 2012\[[@pone.0222105.ref029]\]         28   UD            AV loop   -0.81   0.80    -0.01   25.4   0.950                      COUS = 0.92COTD+0.26                                          Cardiac transplantation, PH

  Darmon 1994\[[@pone.0222105.ref030]\]             63   TEE           AoV       -0.77   0.89    -0.06   19.0   0.940                      COUS = 0.94COTD+0.19                                          CABG or automatic cardioverter defibrillator insertion

  Descorps-Declere 1996\[[@pone.0222105.ref031]\]   28   TEE           LVOT      -1.73   0.89    -0.42   16.0   0.975                      COUS = 0.889COTD+0.74                                         Acutely ill patients with Swan-Ganz catheter, controlled ventilation, sedation and a stable hemodynamic condition

  Dicorte 2000\[[@pone.0222105.ref032]\]            34   TEE           AA        -0.18   1.16    0.49           0.748                      COUS = 1.144COTD-1.625[\*](#t001fn002){ref-type="table-fn"}   CABG

  Eremenko 2010\[[@pone.0222105.ref033]\]           26   UD            AV loop   -2.63   2.62    0.00    22.2   0.910                      COUS = 0.93COTD+0.42                                          Adult post cardiac surgery patients

  Estagnasie 1997\[[@pone.0222105.ref007]\]         22   TEE           MV        -3.40   2.80    0.30           0.780                      COUS = 0.93COTD+0.76                                          Mechanically ventilated patients

  Feinberg 1995\[[@pone.0222105.ref034]\]           29   TEE           LVOT      -1.10   1.30    -0.10   25.0   0.910                      COUS = 0.97COTD-0.03[\*](#t001fn002){ref-type="table-fn"}     Undergone open heart surgery, acute myocardial infarction

  Froese 1991\[[@pone.0222105.ref035]\]             7    TTD           AA        -6.40   12.48   3.04           0.140                                                                                    Patients for elective surgery under general anaesthesia

  Galstyan 2010\[[@pone.0222105.ref036]\]           30   UD            AV loop   -1.72   1.65    0.04    20.0   0.950                      COUS = 1.03COTD-0.24                                          Hematology ICU

  Gassner 2015\[[@pone.0222105.ref010]\]            36   POCUS         CCA       -2.12   2.58    -0.23          0.815                                                                                    surgical and cardiothoracic ICU

  Hammoudi 2016\[[@pone.0222105.ref008]\]           15   3D-TEE        LVOT      -2.37   3.33    0.48    53.0   0.720                                                                                    ICU patients on mechanical ventilation

  Hammoudi(1) 2016\[[@pone.0222105.ref008]\]        15   TEE           LVOT      -1.97   2.74    0.38    44.0   0.780                                                                                    ICU patients on mechanical ventilation

  Hausen 1992\[[@pone.0222105.ref037]\]             9    TTD           AA        -1.56   4.99    1.70           0.248                      COUS = 0.126COTD+0.81                                         Patients after open heart surgery

  Hoole 2008\[[@pone.0222105.ref038]\]              36   RT-3DE        Simpson   -0.84   0.72    -0.06          0.910                      COUS = 0.86COTD+0.45                                          Cardiac transplant assessment

  Horster 2012\[[@pone.0222105.ref039]\]            70   USCOM         TPF/TAF   -2.34   1.62    0.05    29.0   0.890                                                                                    Septic patients

  Horster-1 2012\[[@pone.0222105.ref040]\]          20   USCOM         TPF/TAF   -2.94   3.98    0.52    13.0                                                                                            Mechanically ventilated (PEEP≤10mbar) adult patients with pneumonia and septic shock

  Huntsman1983\[[@pone.0222105.ref041]\]            45   TTE           AA        -1.02   1.26    0.12    17.0   0.940                      COUS = 0.95COTD+0.38                                          ICU patients

  Izzat 1994\[[@pone.0222105.ref042]\]              21   TEE           LVCSA     -3.87   4.81    0.47           0.450                                                                                    Patients undergoing open heart operations

  Izzat(1) 1994\[[@pone.0222105.ref042]\]           21   TEE           PA        -0.78   1.02    0.12           0.950                                                                                    Patients undergoing open heart operations

  Knirsch 2008\[[@pone.0222105.ref043]\]            24   USCOM         AoV       -1.47   1.21    -0.13   36.4                                                                                            Pediatric patients with CHF

  Lee 1988\[[@pone.0222105.ref044]\]                16   TTE           AoV       -0.28   0.15    -0.07          0.940                      COUS = 1.35COTD-1.91[\*](#t001fn002){ref-type="table-fn"}     Sever pregnancy-induced hypertension, eclampsia, hemorrhagic shock, renal failure

  Levy 1985\[[@pone.0222105.ref045]\]               26   TTE           AA        -0.11   0.91    0.40           0.960                      COUS = 0.86COTD+0.29                                          ICU patients including sepsis, pancreatitis, severe pneumonia and cardiac failure

  Marcelino 2006\[[@pone.0222105.ref046]\]          41   TTE           AoV       -1.80   0.60    -0.58   16.0   0.970                      COUS = 0.859COTD+0.47                                         Post liver transplant patients

  Mark 1986\[[@pone.0222105.ref047]\]               16   TEE           AA                                       0.919                      COUS = 1.05COTD+0.000                                         Undergoing cardiac surgery

  Maslow 1996\[[@pone.0222105.ref048]\]             38   TEE           AoV       -0.45   0.45    0.01           0.970                      COUS = 1.03COTD-0.12                                          Adult cardiac surgery patients undergoing general anaesthesia

  Mayer 1995\[[@pone.0222105.ref049]\]              48   TTE           LVOT      -2.09   0.59    -0.75          0.670                                                                                    Aneurysmal clipping

  McLean 1997\[[@pone.0222105.ref050]\]             18   TTE           LVOT      -1.50   1.90    0.20           0.930                                                                                    Pulmonary embolus, cardiogenic shock, septic shock, Legionnaire's disease and perioperative myocardial infarction

  Missant 2008\[[@pone.0222105.ref051]\]            20   TTE           AoV       -1.49   2.38    -0.70   43.0   0.730                      COUS = 1.58COTD-0.13                                          OPCAB

  Moller-Sorensen 2014\[[@pone.0222105.ref018]\]    25   TEE           LVOT      -1.73   1.29    0.20    38.6                                                                                            CABG

  Moxon 2003\[[@pone.0222105.ref052]\]              13   TEE           DA        -2.35   1.89    -0.23          0.810                                                                                    Cardiac surgery patients

  Muhiudeen 1991\[[@pone.0222105.ref053]\]          35   TEE           PA        -2.70   1.30    -0.70   15.0   0.650                      COUS = 0.64COTD+0.97                                          Patients undergoing cardiovascular surgery

  Parra 2008\[[@pone.0222105.ref054]\]              50   TEE           LVOT      -1.21   1.22    0.04    29.1   0.900                                                                                    Patients for elective cardiac surgery with CPB

  Perrino 1998\[[@pone.0222105.ref055]\]            32   TEE           AoV       -1.20   1.08    -0.01   24.0   0.910                                                                                    Patients for either cardiac or noncardiac surgery need for PAC

  Pinto 1994\[[@pone.0222105.ref056]\]              8    TEE           Simpson   -2.80   2.40    -0.20          0.710                      COUS = 0.64COTD+1.57                                          Patients undergoing cardiac surgery

  Poelaert 1999\[[@pone.0222105.ref057]\]           45   TEE           LVOT                      -0.54          0.870                      TEE pwt                                                       CABG

  Poelaert(1) 1999\[[@pone.0222105.ref057]\]        45   TEE           LVOT                      -0.31          0.870                      TEE pwl                                                       CABG

  Poelaert(2) 1999\[[@pone.0222105.ref057]\]        45   TEE           LVOT                      0.21           0.820                      TEE cwt                                                       CABG

  Poelaert(3) 1999\[[@pone.0222105.ref057]\]        45   TEE           LVOT                      0.39           0.840                      TEE cwl                                                       CABG

  Pombo 1971\[[@pone.0222105.ref058]\]              9    TTE           NR                        0.08           0.881                      COUS = 0.932COTD+0.48                                         Myocardial infarction

  Ryan 1992\[[@pone.0222105.ref059]\]               12   TEE           MV        -4.10   2.40    -0.86          0.700                      COUS = 0.954COTD+1.14                                         Undergoing elective major vascular surgery, either\
                                                                                                                                                                                                         aortic aneurysm resection or aorta bifemoral grafting

  Sato 2018\[[@pone.0222105.ref060]\]               12   TEE           PA                                                                                                                                Aortic valvular regurgitation, aortic stenosis.

  Savino 1991\[[@pone.0222105.ref005]\]             33   TEE           PA        -0.97   1.02    0.03    24.0   0.930                      COUS = 1.096COTD-0.336                                        Cardiac surgical patients

  Segal 1991\[[@pone.0222105.ref061]\]              20   Dollper PAC   PA        -1.68   1.42    -0.13   25.0   0.760                      COUS = 0.87COTD+0.44                                          Valvular and nonvalvular cardiac surgery, major intraabdominal vascular surgical procedures

  Shimamoto 1992\[[@pone.0222105.ref062]\]          65   TEE           MV        -2.53   0.83    -0.85                                                                                                   After open heart surgery

  Shimamoto-1 1992\[[@pone.0222105.ref063]\]        42   TEE           MV        -0.12   0.06    -0.03          0.930                      COUS = 0.90COTD+0.12[\*](#t001fn002){ref-type="table-fn"}     Myocardial infarction, angina pectoris, after CABG

  SoutoMoura 2017\[[@pone.0222105.ref064]\]         15   TTE           LVOT      -0.22   0.28    0.03           0.998                                                                                    Cardiac arrest with hypothermia

  SoutoMoura(1) 2017\[[@pone.0222105.ref064]\]      15   TTE           LVOT      -1.60   0.75    -0.43          0.843                                                                                    Cardiac arrest with hypothermia

  Su 2008\[[@pone.0222105.ref065]\]                 15   USCOM         AoV       -0.65   0.92    0.13    8.9    0.988                      COUS = 0.946COTD+0.299                                        Mechanically ventilated patients after liver transplantation

  Su(1) 2008\[[@pone.0222105.ref065]\]              15   USCOM         AoV       -0.51   0.72    0.11    7.2    0.995                      COUS = 0.923COTD+0.569                                        Mechanically ventilated patients after liver transplantation

  Su-1 2008\[[@pone.0222105.ref066]\]               10   USCOM         AoV       -1.06   1.10    0.02    13.0   0.980                                                                                    living donor liver transplants

  Tan 2005\[[@pone.0222105.ref067]\]                22   USCOM         TPF/TAF   -1.43   1.78    0.18                                                                                                    mechanically ventilated patients following cardiac surgery

  Tchorz 2012\[[@pone.0222105.ref013]\]             29   TTE           AoV                       -1.00          0.600                                                                                    critically ill and/or injured\
                                                                                                                                                                                                         patients admitted to a adult trauma center

  Temporelli 2010\[[@pone.0222105.ref068]\]         43   TTE           LVOT      -0.89   0.78    0.40           0.940                      COUS = 1.21COTD+0.016[\*](#t001fn002){ref-type="table-fn"}    advanced heart failure (NYHA Ⅲ-Ⅳ)

  Thom 2009\[[@pone.0222105.ref069]\]               89   USCOM         AoV       -3.01   2.83    -0.10   28.3                                                                                            ICU patients

  Tibbals 1988\[[@pone.0222105.ref070]\]            18   TTE           AA        -0.33   0.25    0.04           0.970                      COUS = 1.03COTD-0.02                                          Children after cardiac surgery on CPB

  Tsutsui 2009\[[@pone.0222105.ref071]\]            29   UD            AV loop   -1.04   1.08    -0.02   23.5   0.910                      COUS = 1.11COTD-0.47                                          Adult patients undergoing abdominal surgery.

  Van den Oever 2007\[[@pone.0222105.ref072]\]      22   USCOM         AoV       -3.66   2.08    -0.79                                                                                                   ASA-PS4 cardiac surgical patients

  Van den Oever(1) 2007\[[@pone.0222105.ref072]\]   22   USCOM         PA        -3.30   2.97    -0.17                                                                                                   ASA-PS4 cardiac surgical patients

  Warth 1984\[[@pone.0222105.ref073]\]              16   TTE           AoV       -2.01   1.87    -0.07   13.0   0.920                      COUS = 0.346COTD+3.33                                         suspected valvular aortic stenosis

  Wong 2008\[[@pone.0222105.ref074]\]               12   USCOM         TPF/TAF   -1.47   2.25    -0.40          0.896                                                                                    Liver transplantation.

  Wong 1990\[[@pone.0222105.ref075]\]               58   TTE           AoV       -2.24   0.86    -0.69          0.900                      COUS = 0.90COTD+ 0.01                                         ICU patients and volunteers

  Wong-1 1990\[[@pone.0222105.ref076]\]             56   TTE           AoV       -4.61   3.03    -0.80          0.510                      COUS = 0.53COTD+ 2.38                                         Mechanically ventilated, cardiac surgery, aortic surgery, dysrhythmias or sepsis patients

  Zhao 2003\[[@pone.0222105.ref077]\]               30   TEE           LVOT      -0.79   0.93    -0.09   24.0   0.870                                                                                    CABG

  Zhao(1) 2003\[[@pone.0222105.ref077]\]            30   TEE           RVOT      -1.10   0.86    -0.18   23.0   0.880                                                                                    CABG

  Zhao(2) 2003\[[@pone.0222105.ref077]\]            30   TEE           AoV       -0.65   0.99    0.11    27.0   0.840                                                                                    CABG
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*US* ultrasound, *CCA* common carotid artery, *LOA* limits of agreement, *PE* percentage error, *R* linearly dependent coefficient, *PA* pulmonary artery, *TD* thermodilution technique, *COUS* cardiac output measurement by ultrasound, *COTD* cardiac output measurement by thermodilution, *USCOM* ultrasonic cardiac output monitor, *TTE* transthoracic echocardiography, *TEE* transoesophageal echocardiography, *UFP* ultrasonic flow probe, *UD* ultrasound dilution, *RT-3DE* real-time 3D echocardiography, *POCUS* point-of-care ultrasound, *LVOT* left ventricular outflow tract, *RVOT* right ventricular outflow tract, *ACM* automated cardiac output measurement, *AA* ascending aorta, *DA* descending aorta, *AOV* aortic valve, *MV* mitral valve, *TPF* transpulmonary blood flow, *TAF* transaortic blood flow, *AV loop* arteriovenous loop, *cwt* continuous wave Doppler transverse plane, *pwt* pulsed wave Doppler transverse plane, *cw*l continuous wave Doppler longitudinal plane, *pwl* pulsed wave Doppler longitudinal plane, *PiCCO* pulse indicator continuous cardiac output, *CABG* coronary artery bypass surgery, *ASA-PS4* The American Society of Anesthesiologists Physical Status Score 4 class, *CPB* Cardiopulmonary bypass, *CHF* Congestive heart failure, *PH* Pulmonary hypertension, *MVD* Mitral valve disease, *NR* not reported.

\**The* equation was derived from the transformation.

Characteristics and qualities of included studies {#sec010}
-------------------------------------------------

Sixty-nine articles involving 1996 subjects were included. Of these studies, the number of patients ranged from 6 to 89. CO measurements were performed using TTE in 19 studies\[[@pone.0222105.ref002], [@pone.0222105.ref013], [@pone.0222105.ref023], [@pone.0222105.ref026], [@pone.0222105.ref027], [@pone.0222105.ref041], [@pone.0222105.ref044]--[@pone.0222105.ref046], [@pone.0222105.ref049]--[@pone.0222105.ref051], [@pone.0222105.ref058], [@pone.0222105.ref064], [@pone.0222105.ref068], [@pone.0222105.ref070], [@pone.0222105.ref073], [@pone.0222105.ref075]\], TEE in 24 \[[@pone.0222105.ref006]--[@pone.0222105.ref008], [@pone.0222105.ref018], [@pone.0222105.ref020], [@pone.0222105.ref030]--[@pone.0222105.ref032], [@pone.0222105.ref034], [@pone.0222105.ref042], [@pone.0222105.ref047], [@pone.0222105.ref048], [@pone.0222105.ref052]--[@pone.0222105.ref057], [@pone.0222105.ref059]--[@pone.0222105.ref063], [@pone.0222105.ref077]\], USCOM in 14 \[[@pone.0222105.ref004], [@pone.0222105.ref019], [@pone.0222105.ref022], [@pone.0222105.ref025], [@pone.0222105.ref028], [@pone.0222105.ref039], [@pone.0222105.ref040], [@pone.0222105.ref043], [@pone.0222105.ref065]--[@pone.0222105.ref067], [@pone.0222105.ref069], [@pone.0222105.ref072], [@pone.0222105.ref074]\], UD in 4 \[[@pone.0222105.ref029], [@pone.0222105.ref033], [@pone.0222105.ref036], [@pone.0222105.ref071]\], and other types of echocardiography in 7 \[[@pone.0222105.ref010], [@pone.0222105.ref021], [@pone.0222105.ref024], [@pone.0222105.ref035], [@pone.0222105.ref037], [@pone.0222105.ref038], [@pone.0222105.ref061]\]. CO measurements were performed in the AA in 13 studies \[[@pone.0222105.ref002], [@pone.0222105.ref004], [@pone.0222105.ref019], [@pone.0222105.ref024], [@pone.0222105.ref027], [@pone.0222105.ref028], [@pone.0222105.ref032], [@pone.0222105.ref035], [@pone.0222105.ref037], [@pone.0222105.ref041], [@pone.0222105.ref045], [@pone.0222105.ref047], [@pone.0222105.ref070]\], AOV in 18 \[[@pone.0222105.ref006], [@pone.0222105.ref013], [@pone.0222105.ref022], [@pone.0222105.ref023], [@pone.0222105.ref030], [@pone.0222105.ref043], [@pone.0222105.ref044], [@pone.0222105.ref046], [@pone.0222105.ref048], [@pone.0222105.ref051], [@pone.0222105.ref055], [@pone.0222105.ref065], [@pone.0222105.ref066], [@pone.0222105.ref069], [@pone.0222105.ref072], [@pone.0222105.ref073], [@pone.0222105.ref075]--[@pone.0222105.ref077]\], and LVOT in 12 \[[@pone.0222105.ref008], [@pone.0222105.ref018], [@pone.0222105.ref021], [@pone.0222105.ref031], [@pone.0222105.ref034], [@pone.0222105.ref049], [@pone.0222105.ref050], [@pone.0222105.ref054], [@pone.0222105.ref057], [@pone.0222105.ref064], [@pone.0222105.ref068], [@pone.0222105.ref077]\] with VTI. Further, CO measurements were performed in 5 studies in the PA \[[@pone.0222105.ref002], [@pone.0222105.ref005], [@pone.0222105.ref053], [@pone.0222105.ref060], [@pone.0222105.ref061]\], and CO measurement using the Simpson method in 3\[[@pone.0222105.ref020], [@pone.0222105.ref038], [@pone.0222105.ref056]\]. Of these studies, Bland-Altman analyses were used in 56 studies, and the LOA and bias were available in 59. Linear regression analyses were used in 54 studies, and 35 regression equations were acquired. Correlation analyses were used in most studies, and the correlation coefficient (R value) was obtained except for the other 15 studies ([Table 2](#pone.0222105.t002){ref-type="table"}). The methodological qualities of the included studies were evaluated according to the tailored QUADAS-2. The results are shown in [Fig 2](#pone.0222105.g002){ref-type="fig"} and [S1 Fig](#pone.0222105.s003){ref-type="supplementary-material"}.

![Diagram demonstrating the studies' percentage compliance, risk of bias, and applicability concerns.](pone.0222105.g002){#pone.0222105.g002}

CO evaluation using different types of Doppler {#sec011}
----------------------------------------------

Of these included studies, there were 41 studies with 49 CO measured results, and 1522 patients were included in the meta-analysis; no significant differences were observed between US and TD (random effects model: MD, -0.14; 95% confidence interval \[CI\], -0.30 to 0.02; *P* = 0.08). The subgroup analyses were conducted using different types of echocardiography techniques. In 19 of the TTE studies, 12 with 14 sets of data and 290 patients were included in the meta-analysis. The result showed no significant differences between TTE and TD (random effects model: MD, -0.28; 95% CI, -0.71 to 0.15; *P* = 0.20). In 24 of the TEE studies, 13 with 19 sets of data and 606 patients were included in the meta-analysis. The result showed that no significant differences were observed between TEE and TD (random effects model: MD, 0.00; 95% CI, -0.12 to 0.11; *P* = 0.98). In 13 of the USCOM studies, 10 with 10 sets of data and 356 patients were included in the meta-analysis. No significant differences were observed between USCOM and TD (random effects model: MD, -0.16; 95% CI, -0.61 to 0.28; *P* = 0.47). No significant differences were observed in four studies between UD and TD (random effects model: MD, 0.00; 95% CI, -0.43 to 0.44; *P* = 0.99), and no significant differences were observed in the other 4 studies between other types of methods and TD (random effects model: MD, -0.56; 95% CI, -1.25 to 0.14; *P* = 0.12) ([Table 2](#pone.0222105.t002){ref-type="table"} and [S2 Fig](#pone.0222105.s004){ref-type="supplementary-material"}). The sensitivity analysis showed that no change occurred in the overall effect and subgroup analysis effect when some studies were omitted up to the acceptable heterogeneity ([Table 3](#pone.0222105.t003){ref-type="table"} and [S3 Fig](#pone.0222105.s005){ref-type="supplementary-material"}).

10.1371/journal.pone.0222105.t002

###### Meta-analyses of the cardiac output measurement by echocardiography (US) vs. thermodilution (TD).

![](pone.0222105.t002){#pone.0222105.t002g}

  Outcome or Subgroup    Studies   Participants   Heterogeneity   Meta-analysis model   Effect Estimate                            
  ---------------------- --------- -------------- --------------- --------------------- ----------------- ------------------------ ------
  1 All                  43        1522           67              \<0.01                IV, Random        -0.14 \[-0.30, 0.02\]    0.08
      1.1 TTE            12        290            85              \<0.01                IV, Random        -0.28 \[-0.71, 0.15\]    0.20
      1.2 TEE            13        606            0               0.98                  IV, Random        0.00 \[-0.12, 0.11\]     0.98
      1.3 USCOM          10        356            71              0.001                 IV, Random        -0.16 \[-0.61, 0.28\]    0.47
      1.4 UD             4         113            0               1.00                  IV, Random        0.00 \[-0.43, 0.44\]     0.99
      1.5 Others types   4         157            73              0.01                  IV, Random        -0.56 \[-1.25, 0.14\]    0.12
  2 All                  43        1446           68              \<0.01                IV, Random        -0.15 \[-0.31, 0.00\]    0.06
      2.1AA              6         202            64              0.01                  IV, Random        -0.37 \[-0.71, -0.01\]   0.05
      2.2 AOV            15        463            75              \<0.01                IV, Random        -0.03 \[-0.31, 0.25\]    0.83
      2.3 LVOT           8         418            55              0.01                  IV, Random        -0.06 \[-0.32, 0.21\]    0.67
      2.4 PA             2         44             0               0.97                  IV, Random        -0.09 \[-0.63, 0.44\]    0.73
      2.5 AV loop        3         87             0               1.00                  IV, Random        -0.01 \[-0.46, 0.45\]    0.97
      2.6 TPF/TAF        3         102            0               0.81                  IV, Random        0.05 \[-0.58, 0.68\]     0.88
      2.7 Others sites   6         130            77              \<0.01                IV, Random        -0.53 \[-1.40, 0.33\]    0.23

*TTE* transthoracic echocardiography, *TEE* transoesophageal echocardiography, *USCOM* ultrasonic cardiac output monitor, *UD* ultrasound dilution, *AOV* aortic valve, *LVOT* left ventricular outflow tract, *AA* ascending aorta, *PA* pulmonary artery, *AV loop* arteriovenous loop, *TPF* transpulmonary blood flow, *TAF* transaortic blood flow, *IV* inverse variance, *MD* mean difference, *CI* confidence interval

10.1371/journal.pone.0222105.t003

###### Sensitivity analysis of high heterogeneity outcomes in meta-analysis.

![](pone.0222105.t003){#pone.0222105.t003g}

  -------------------------------------------------------------------------------------------------------------------------------
  Heterogeneity outcomes   Participants   Omitted\   Heterogeneity   Meta-analysis\   Outcomes                             
                                          studies                    model                                                 
  ------------------------ -------------- ---------- --------------- ---------------- ----------- ------------------------ ------
  3 Types of Doppler       1407                      0%              0.99             IV, Fixed   0.00 \[-0.08, 0.09\]     0.94

      3.1 TTE              228                       30%             0.28             IV, Fixed   0.14 \[-0.12, 0.41\]     0.28

      3.2 TEE              606                       0%              1.00             IV, Fixed   0.00 \[-0.12, 0.11\]     0.98

      3.3 USCOM            336                       0%              0.94             IV, Fixed   -0.03 \[-0.18, 0.25\]    0.75

      3.4 UD               113                       0%              1.00             IV, Fixed   0.00 \[-0.43, 0.44\]     0.99

      3.5 Others           124                       0%              0.98             IV, Fixed   -0.19 \[-0.47, 0.09\]    0.18

  4 Sites                  1351                      0%              0.77             IV, Fixed   -0.02 \[-0.11, 0.06\]    0.63

      4.1 AA               192                       15%             0.32             IV, Fixed   -0.20 \[-0.39, -0.00\]   0.04

      4.2 AOV              431                       0%              0.65             IV, Fixed   0.02 \[-0.15, 0.19\]     0.80

      4.3 LVOT             385                       0%              0.57             IV, Fixed   0.06 \[-0.08, 0.19\]     0.41

      4.4 PA               44                        0               0.97             IV, Fixed   -0.09 \[-0.63, 0.44\]    0.73

      4.5 AV loop          87                        0               1.00             IV, Fixed   -0.01 \[-0.46, 0.45\]    0.97

      4.6 TPF/TAF          102                       0               0.81             IV, Fixed   0.05 \[-0.58, 0.68\]     0.88

      4.7 Others           110                       0%              0.98             IV, Fixed   -0.15 \[-0.50, 0.20\]    0.40
  -------------------------------------------------------------------------------------------------------------------------------

*TTE* transthoracic echocardiography, *TEE* transoesophageal echocardiography, *USCOM* ultrasonic cardiac output monitor, *UD* ultrasound dilution, *AOV* aortic valve, *LVOT* left ventricular outflow tract, *AA* ascending aorta, *PA* pulmonary artery, *AV loop* arteriovenous loop, *TPF* transpulmonary blood flow, *TAF* transaortic blood flow, *IV* inverse variance, *MD* mean difference, *CI* confidence interval

CO evaluation at different sites {#sec012}
--------------------------------

In six studies, the AA was used to measure CO by Doppler, and six studies were included in the meta-analysis. Significant differences were observed in the use of US at AA with TD (random effects model: MD, -0.37; 95% CI, -0.71 to -0.11; *P* = 0.05). Moreover, no significant differences were observed in the use of US at AOA (random effects model: MD, -0.03; 95% CI, -0.31 to 0.25; *P* = 0.83), LVOT (random effects model: MD, -0.06; 95% CI, -0.32 to 0.21; *P* = 0.67), PA (random effects model: MD, -0.09; 95% CI, -0.63 to 0.44; *P* = 0.73), AV loop (random effects model: MD, -0.01; 95% CI, -0.46 to 0.45; P = 0.97), TPF/TAF (random effects model: MD, 0.05; 95% CI, -0.58 to 0.68; *P* = 0.88), and other sites (random effects model: MD, -0.53; 95% CI, -1.40 to 0.33; *P* = 0.23) ([Table 2](#pone.0222105.t002){ref-type="table"} and [S4 Fig](#pone.0222105.s006){ref-type="supplementary-material"}). The sensitivity analysis showed no changes in the overall effect and the subgroup analyses ([Table 3](#pone.0222105.t003){ref-type="table"} and [S5 Fig](#pone.0222105.s007){ref-type="supplementary-material"}).

Bland-Altman analyses and regression analyses {#sec013}
---------------------------------------------

In all studies, the median of bias between US and TD was -0.12 (ranged from -2.50 to 3.04 L/min). The median of LOA was 0.94 L/min (ranged from ±0.05 to ±4.72 L/min). Twenty-eight studies reported that the PE and the median were 24.3% (ranged from 7.2% to 53%). The median of R (correlation coefficient) was 0.827 (ranged from 0.140 to 0.998). The slope ranged from 0.126 to 1.58, and the intercept ranged from -1.91 to 3.55 in the 35 regression equations ([Table 1](#pone.0222105.t001){ref-type="table"}).

Publication bias {#sec014}
----------------

The funnel plot was roughly symmetrical ([S5 Fig](#pone.0222105.s007){ref-type="supplementary-material"}). Egger's test revealed no publication bias in the literature (*P* = 0.500) ([S6 Fig](#pone.0222105.s008){ref-type="supplementary-material"}).

Discussion {#sec015}
==========

In this systematic review, we included 68 studies, of which 43 studies reported data on CO measurement and were included in the meta-analysis. The overall effect showed that no significant difference was observed between echocardiography and TD in measuring CO; the subgroup analysis showed no significant differences in the different types. In all sites, the difference was founded only in AA. Further, the sensitivity analysis showed no change in the results. However, there was a wide range in bias, LOA, PE, and correlation coefficient of the two technologies and was beyond the clinically acceptable range in some studies.

In these different types of echocardiography, the sensitivity analysis showed that the TEE, USCOM, and UD had hairline bias (≤0.1 L/min) with TD; TEE had the lowest standard error and maximum weight followed by TTD. The UD had a small mean difference, but with wide 95% CI. CO could be easily overestimated using TTE instead of using TD, and underestimated using other types of echocardiography (ACM, NICO, point-of-care US, and Doppler PA catheter) despite the differences not having statistical significance. Therefore, we speculate that TEE was the preferred method because it can obtain more accurate results in the measurement of CO. Considering that TEE is semi-invasive and UD can only be used for specific population, USCOM can be the first choice for noninvasive echocardiography for the measurement of CO.

The sites of the ultrasonic probe will also have an effect on the test results. In our meta-analysis, no statistical difference was found except for the measurement of CO in the AA. The lowest mean difference of CO comes from PA, compared with the TD, followed by AV loop. However, the method of measuring PA CO used a PA catheter ultrasound probe and was an invasive procedure \[[@pone.0222105.ref059]\]. The AV loop used in UD is also based on an invasive procedure\[[@pone.0222105.ref028], [@pone.0222105.ref033], [@pone.0222105.ref035], [@pone.0222105.ref068]\]. In these studies, more researchers were willing to measure CO in the AOV and LVOT, with mean differences of \<0.1 L/min and a narrower LOA. Therefore, the AOV and LVOT as the recommended sampling locations for CO detection are feasible. This finding is also consistent with the recommendation of the American ultrasound guidelines \[[@pone.0222105.ref078]\].

In all these studies, the largest bias and LOA (bias = 3.04 L/min, LOA = ±9.44 L/min) were found in a study with the ABCOM 1 transtracheal Doppler (TTD) versus TD \[[@pone.0222105.ref034]\] and with the lowest correlation coefficient (R = 0.14). TTD system requires a special TTD endotracheal tube, in which the tip was embedded with an ultrasonic probe; it can only be used in patients with mechanical ventilation. In this study, seven patients with 36 simultaneous measurements were compared. We speculated that the TTD measurements accounted for most of the between-technique variability. Obtaining and maintaining good Doppler signals were difficult and time-consuming in TTD and were considered possible causes of error. Hausen et al. \[[@pone.0222105.ref037]\] also compared TTD and TD. They suggested that the TTD system does not provide accurate CO determinations (bias = 1.70 L/min, LOA = ±3.29 L/min, R = 0.248) and that several reasons can affect its accuracy and restrict its wider use, such as cuff deflation for \>10 min, which cannot be tolerated by ICU doctors, sensitivity to patient movement, and that an optimal signal cannot often be attained if the probe is not in the appropriate place.

The bias in three studies\[[@pone.0222105.ref002], [@pone.0222105.ref021], [@pone.0222105.ref025]\] was \> 2.0 L/min. One of these studies\[[@pone.0222105.ref021]\] used the ACM to monitor the CO in patients with high cardiac output (pregnant and pre-eclamptic women) and found that it was inaccurate compared with TD. Another study\[[@pone.0222105.ref002]\] found that the mean difference was larger in the spontaneous ventilation state than the intermittent positive pressure ventilation and apnea state. One possible reason was that the patients were not sedated during spontaneous ventilation; thus, the CO was increased. Cariou et al. \[[@pone.0222105.ref025]\] compared the descending aortic blood flow using a pulse Doppler velocimeter with CO. Although the authors thought that the descending aortic blood flow determination had good correlation and consistency with TD in CO and that descending aortic blood flow provided a reliable noninvasive tool for estimating CO, the mean difference was obviously due to the descending aortic blood flow as a fraction of the CO.

Critchley and Critchley \[[@pone.0222105.ref079]\] thought that it can be acceptable clinically when the PE is \<30%. They suggest that if the PE between the two methods is ≤±30%, then the two methods are interchangeable. In our studies, although the median of PE was 23.8%, the PE of the six studies \[[@pone.0222105.ref002], [@pone.0222105.ref008], [@pone.0222105.ref018], [@pone.0222105.ref024], [@pone.0222105.ref043], [@pone.0222105.ref051]\] was \>30%. Missant et al. \[[@pone.0222105.ref051]\] used Doppler echocardiography during off-pump coronary artery bypass grafting and believed that Doppler echocardiography was not always feasible when the heart was displaced from the esophagus and had lower accuracy; The accuracy in CO measurement may have been affected in three studies that included special patients or scenarios (Knirsch et al. \[[@pone.0222105.ref043]\] had used USCOM in children with congenital heart disease; Botero et al. \[[@pone.0222105.ref024]\] used NICO during cardiopulmonary bypass; and Castor et al. \[[@pone.0222105.ref002]\] used NICO in patients with low sedation levels during spontaneous ventilation). Moller-Sorensen et al. \[[@pone.0222105.ref018]\] thought that the possible explanation was that the SV is calculated from two variables (LVOT, CSA, and the VTi); measurements were made irrespective of the ventilatory cycle, arrhythmias, and the patients with different scenarios. Therefore, we should pay more attention to the evaluation of ultrasound CO results, when the cardiac function or physiological structural change occurs in some patients with heart disease or in special situations.

Moreover, imprecision in echocardiography CO measurements may be induced by technical or operator factors. By improving the operation level, repeated measurement may reduce the measurement error. In our meta-analysis, self-control was used in all studies, and most of the studies used repeated measurements and blinding methods. Therefore, the quality of literature was not evaluated.

Other limitations of this study include the following: (1) no further subgroup analysis was conducted on the research subjects and disease types due to the limitation of data integrity and the diversity of diseases; (2) determination of the best CO test method was difficult, as both have advantages and limitations; (3) the linear equations were not overfitted because finding a general linear equation to express the relationship between US and TD in CO measurement for the inconsistency of the research subjects, ultrasonic type, and sites is difficult.

Conclusions {#sec016}
===========

This systematic review and meta-analysis showed that the overall effect of the CO measurements by echocardiography or TD has no significant difference. TEE can be the preferred method with accurate results and USCOM can be a good choice for its noninvasiveness in CO measurement; the AOV and LVOT can be the recommended sampling location. However, in some special scenarios, such as high CO, low sedation, or with physiological structural changes, the accuracy of CO measurement by echocardiography is questionable.
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###### Tailored QUADAS-2 to assess risk of bias and applicability judgments.

(DOC)

###### 

Click here for additional data file.
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###### Diagram demonstrating the assessment of bias for each study included in our analysis.

(TIF)
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###### Forest plot of comparison in cardiac output measurement and subgroup analysis with different types of echocardiography (US) vs. thermodilution (TD).

*IV* inverse variance, *CI* confidence interval, *MD* mean difference.

(TIF)

###### 

Click here for additional data file.

###### Forest plot of sensitivity analysis of cardiac output measurement and subgroup analysis with different types of echocardiography (US) vs. thermodilution (TD).

*IV* inverse variance, *CI* confidence interval, *MD* mean difference.

(TIF)

###### 

Click here for additional data file.

###### Forest plot of comparison of cardiac output measurement and subgroup analysis with different sites for echocardiography (US) vs. thermodilution (TD).

*IV* inverse variance, *CI* confidence interval, *MD* mean difference.

(TIF)

###### 

Click here for additional data file.

###### Forest plot of sensitivity analysis of cardiac output measurement and subgroup analysis with different sites for echocardiography (US) vs. thermodilution (TD).

*IV* inverse variance, *CI* confidence interval, *MD* mean difference.

(TIF)
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Click here for additional data file.

###### Funnel plot for publication bias in cardiac output measurement between echocardiography (US) vs. thermodilution (TD) (Egger's test, *P* = 0.500).

(TIF)

###### 

Click here for additional data file.
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